[1]
L. M. Furtado, “Cetuximab has an inhibitory effect on cell motility in SCC-4 oral squamous cell carcinoma cell line”, Cell Mol Biol (Noisy-le-grand), vol. 63, no. 9, pp. 13–17, Sep. 2017.